0001178913-23-002730.txt : 20230807 0001178913-23-002730.hdr.sgml : 20230807 20230807160522 ACCESSION NUMBER: 0001178913-23-002730 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 EFFECTIVENESS DATE: 20230807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RedHill Biopharma Ltd. CENTRAL INDEX KEY: 0001553846 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-488980 FILM NUMBER: 231147566 BUSINESS ADDRESS: STREET 1: 21 HA'ARBA'A STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 BUSINESS PHONE: 972-3-541-3131 MAIL ADDRESS: STREET 1: 21 HA'ARBA'A STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 D 1 primary_doc.xml X0708 D LIVE 0001553846 RedHill Biopharma Ltd. 21 HA'ARBA'A STREET TEL AVIV L3 ISRAEL 6473921 972-3-541-3131 ISRAEL None None Corporation true Dror Ben-Asher 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Director Razi ingber 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Kenneth Reed 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Shmuel Cabilly 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Ofer Tsimchi 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Eric Swenden 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Rick Scruggs 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Alla Felder 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Director Gilead Raday 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Adi Frish 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Guy Goldberg 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Reza Fathi 21 HA'ARBA'A STREET Tel Aviv L3 ISRAEL 6473921 Executive Officer Pharmaceuticals $25,000,001 - $100,000,000 06b false 2023-07-21 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 NY NEW YORK false 2700000 2700000 0 This Form D is being filed in connection with the issuance of warrants to purchase up to 1,500,000 ADSs an exercise price of $1.80 per ADS, with each ADS each representing 400 ordinary shares, par value NIS 0.01 per share, of the Company. false 1 283695 0 The placement agent (or its designees) also received warrants to purchase 168,115 American Depositary Shares at an exercise price of $1.6875 per ADS,each representing 400 ordinary shares, par value NIS 0.01 per share, of the Company. 0 false RedHill Biopharma Ltd. /s/ Dror Ben-Asher Dror Ben-Asher Chief Executive Officer 2023-08-07